You also may be interested in...
Policy
This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components.
Policy
Establishes the DHA's plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic
Policy
Establishes the DHA's procedures to set procedures, responsibilities, and implement guidance for administering the DHA RA Program in accordance with federal guidelines.
- Identification #: 1020.01
- Date: 11/2/2020
- Type: Administrative Instructions
- Topics:
Disability Evaluation
Policy
This PGI provides standard language that shall be included in all purchased and non-purchased care solicitations and contracts where the contractor’s performance involves access to PII/PHI (unless those solicitations and contracts incorporate the TRICARE Manuals in their entirety, in which case this PGI does not apply).
Policy
CMS Checklist for MTF Claims
- Identification #: N/A
- Date: 10/8/2020
- Type: Guidelines
- Topics:
N/A
Policy
In accordance with the authority in DOD Directive 5124.02, this issuance establishes policy, assigns responsibilities, and prescribes procedures regarding the standards for military service accession, retention, separation, in-service transition, and medical care for Service members and applicants for accession to the Military Services with gender dysphoria or who are transgender, as applicable.
Policy
The Department of Defense (DOD) Pharmacy and Therapeutics (P&T) Committee (henceforth, P&T Committee) is responsible for development and maintenance of the TRICARE Uniform Formulary. This charter outlines the roles and responsibilities of the DOD P&T Committee.
- Identification #: N/A
- Date: 8/31/2020
- Type: Guidelines
- Topics:
N/A
Policy
Implements instructions, assigns responsibilities, and prescribes procedures for the DOD Northern Hemisphere (NH) and Southern Hemisphere (SH) Seasonal influenza vaccination program.
Policy
Process for requesting immunization exemptions, pursuant to the Navy Military Personnel Manual.
Policy
The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.
Policy
This Memorandum of Understanding (MOU) rescind and replace the Supplement to the Department of Veterans Affairs (VA) and the Department of Defense (DOD) Health Care Resources Sharing Guidelines, dated December 5, 2016. VA and DOD are collectively referred to in the MOU as “Partners”.
- Identification #: Agreement Number DHA-2019-S-1214
- Date: 4/20/2020
- Type: Memorandums
- Topics:
N/A
Policy
This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), establishes the Defense Health Agency’s procedures to authorize the procurement of all ruminant meat (beef, sheep, goat, bison, etc.) and edible products from ruminants of overseas origin. DOD procurement of ruminant meat and meat products will align with current United States Department of Agriculture (USDA) restrictions and residual risk mitigation measures for Bovine Spongiform Encephalopathy (BSE).
- Identification #: 20-003
- Date: 4/10/2020
- Type: DHA Interim Procedures Memorandum
- Topics:
N/A
Policy
This memorandum directs all Military Treatment Facility (MTF) and Dental Treatment Facility (DTF) Commanders and Directors to immediately postpone all elective surgeries, invasive procedures, and dental procedures performed on beneficiaries of the MTFs and DTFs with the exceptions outlined below. This includes aerosol-producing procedures, such as endoscopies, bronchoscopies, pulmonary function tests, and sleep continuous positive airway pressure (CPAP) titrations. This policy is effective March 31, 2020, and will remain in place for 60 days.
- Identification #: N/A
- Date: 3/24/2020
- Type: Memorandums
- Topics:
N/A
Showing results 46 - 60
Page 4 of 70